𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor-β1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts

✍ Scribed by Robert A. R. Hurta; Arnold H. Greenberg; Jim A. Wright


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
787 KB
Volume
152
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Transforming growth factor‐β~1~ (TGF‐β~1~) stimulated DNA synthesis (3‐fold) in BALBc/3T3 fibroblasts following 24 hours of growth factor exposure. Since ribonucleotide reductase is important for the coordination of DNA synthesis and cell proliferation, we investigated the hypothesis that cells like BALB/c 3T3, which are TGF‐β~1~ responsive, would exhibit modifications in expression of the gene for ribonucleotide reductase following growth factor treatment. We observed 2.6, 4.1, and 4.8‐fold increases in ribonucleotide reductase activity following TGF‐β~1~ exposure for 6, 12, and 24 hours, respectively. Increased ribonucleotide reductase R2 gene expression (3, 3.7, and 4.5‐fold) and R1 gene expression (2, 2.5, and 2.6‐fold) were observed following 6, 12, and 24 hours of TGF‐β~1~ treatment, respectively. Western blots indicated 2.2, 3.1, and 4.1‐fold increases in protein R2 levels at 6, 12, and 24 hours exposure to TGF‐β~1~, whereas 2.6 and 3.3‐fold elevations in R1 protein levels were observed at 12 and 24 hours postTGF‐β~1~ exposure. These TGF‐β~1~ mediated modifications in ribonucleotide reductase gene expression occurred, in part, prior to any detectable changes in the rate of DNA synthesis, demonstrating alterations in the normal regulation of ribonucleotide reductase. Furthermore, these alterations could be markedly reduced by prolonged pretreatment with 12‐0‐tetradecanoylphorbol‐13‐acetate (R2 gene expression increased by only 1.3, 1.5 and 2.3‐fold after 6, 12, and 24 hours of TGF‐β~1~ treatment, respectively), suggesting a role for a protein kinase C pathway in the TGF‐β~1~ regulated changes in ribonucleotide reductase gene expression. These results indicate for the first time that TGF‐β~1~ can regulate the expression of the two genes for ribonucleotide reductase in BALB/c 3T3 fibroblasts, and suggest that regulation of these genes plays an important role in critical events involved in growth factor modulation of normal and transformed cell proliferation. © 1992 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Internalization of transforming growth f
✍ Joan Massagué; Brenda Kelly 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 977 KB

The fate of 1251-labeled transforming growth factor-@ (1251-TCF@) after binding to its cells surface receptor has been investigated in BALB/c 3T3 mouse fibroblasts. Binding of 1251-TGF@ to cellular receptors at 4OC is pH-sensitive, 0 1986 ALAN R. LISS, INC.

Transforming growth factor β1 augments m
✍ Rebecca S. Gilbert; Srinivasa T. Reddy; Dr. Dean A. Kujubu; Weilin Xie; Dr. Stev 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

## Abstract Transforming growth factor‐beta (TGF‐beta), a potent cytokine, modulates a wide variety of biological responses. Among its actions, TGF‐beta can augment prostaglandin synthesis in several cell types. Although TGF‐beta alone has no effect on prostaglandin production in Swiss 3T3 cells, w

Phenotypic change and altered protein ex
✍ Chaoying He; B. Alex Merrick; Lora L. Witcher; Rachel M. Patterson; Dennis R. Da 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 920 KB

## Abstract The morphology, growth properties and cellular protein patterns from parent and two transformed C3H10T1/2 cell lines were analyzed to associated the phenotypic and protein differences with cell transformation. Transformed 10T1/2 cells were obtained by colony isolation after exposure of

Transforming growth factor-β1 and bone m
✍ Traudy Avila; Arturo Andrade; Ricardo Felix 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

## Abstract In the developing skeletal muscle, fusion of myoblasts and myotube formation is a process that involves Ca^2+^ influx through T‐type (Ca~V~3) channels. Treatment of myoblasts with transforming growth factor‐β1 (TGF‐β1) and bone morphogenetic protein‐2 (BMP‐2) decreases the number of Ca~